{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:46:49Z","timestamp":1789987609487,"version":"4.0.1"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,1]]},"DOI":"10.1093\/aje\/kwu176","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T05:34:14Z","timestamp":1409290454000},"page":"687-695","source":"Crossref","is-referenced-by-count":91,"title":["Epstein-Barr Virus Antibodies and the Risk of Associated Malignancies: Review of the Literature"],"prefix":"10.1093","volume":"180","author":[{"given":"Anna E.","family":"Coghill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,8,28]]},"reference":[{"issue":"7","key":"key\n\t\t\t\t20170522092625_KWU176C1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med."},{"issue":"1","key":"key\n\t\t\t\t20170522092625_KWU176C2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1040-8428(00)00046-9","article-title":"Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications","volume":"34","author":"Hsu","year":"2000","journal-title":"Crit Rev Oncol Hematol."},{"issue":"10","key":"key\n\t\t\t\t20170522092625_KWU176C3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer."},{"issue":"3","key":"key\n\t\t\t\t20170522092625_KWU176C4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","article-title":"EBV persistence in memory B cells in vivo","volume":"9","author":"Babcock","year":"1998","journal-title":"Immunity."},{"issue":"6","key":"key\n\t\t\t\t20170522092625_KWU176C5","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.4049\/jimmunol.165.6.2975","article-title":"EBV persistence involves strict selection of latently infected B cells","volume":"165","author":"Joseph","year":"2000","journal-title":"J Immunol."},{"issue":"11 Pt 2","key":"key\n\t\t\t\t20170522092625_KWU176C6","first-page":"3","article-title":"Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study\u2014a review","author":"de-Th\u00e9","year":"1975","journal-title":"IARC Sci Publ"},{"issue":"5","key":"key\n\t\t\t\t20170522092625_KWU176C7","doi-asserted-by":"crossref","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","article-title":"Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6\u201319, 2003\u20132010","volume":"8","author":"Dowd","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"key\n\t\t\t\t20170522092625_KWU176C8","doi-asserted-by":"crossref","first-page":"e19100","DOI":"10.1371\/journal.pone.0019100","article-title":"Fluctuations of Epstein-Barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up","volume":"6","author":"Cao","year":"2011","journal-title":"PLoS One."},{"issue":"26","key":"key\n\t\t\t\t20170522092625_KWU176C9","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa011610","article-title":"Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men","volume":"345","author":"Chien","year":"2001","journal-title":"N Engl J Med."},{"issue":"4","key":"key\n\t\t\t\t20170522092625_KWU176C10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjc.6603609","article-title":"Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma","volume":"96","author":"Ji","year":"2007","journal-title":"Br J Cancer."},{"issue":"7","key":"key\n\t\t\t\t20170522092625_KWU176C11","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/1078-0432.CCR-10-1681","article-title":"Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families","volume":"17","author":"Yu","year":"2011","journal-title":"Clin Cancer Res."},{"issue":"3","key":"key\n\t\t\t\t20170522092625_KWU176C12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/aje\/kws403","article-title":"Invited commentary: Epstein-Barr virus-based screening for the early detection of nasopharyngeal carcinoma: a new frontier","volume":"177","author":"Hildesheim","year":"2013","journal-title":"Am J Epidemiol."},{"issue":"3","key":"key\n\t\t\t\t20170522092625_KWU176C13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/aje\/kws404","article-title":"Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China","volume":"177","author":"Liu","year":"2013","journal-title":"Am J Epidemiol."},{"key":"key\n\t\t\t\t20170522092625_KWU176C14","volume-title":"Immunobiology","author":"Janeway","year":"2008","edition":"7th ed."},{"issue":"11","key":"key\n\t\t\t\t20170522092625_KWU176C15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199509143331103","article-title":"Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma","volume":"333","author":"Pathmanathan","year":"1995","journal-title":"N Engl J Med"},{"issue":"6","key":"key\n\t\t\t\t20170522092625_KWU176C16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1044579X0200086X","article-title":"Epstein-Barr virus in the pathogenesis of NPC","volume":"12","author":"Raab-Traub","year":"2002","journal-title":"Semin Cancer Biol."},{"issue":"4","key":"key\n\t\t\t\t20170522092625_KWU176C17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/scbi.1996.0023","article-title":"Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma","volume":"7","author":"Niedobitek","year":"1996","journal-title":"Semin Cancer Biol."},{"issue":"3","key":"key\n\t\t\t\t20170522092625_KWU176C18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0964-1955(95)00093-3","article-title":"Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients","volume":"32B","author":"Vera-Sempere","year":"1996","journal-title":"Eur J Cancer B Oral Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170522092625_KWU176C19","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.66.5.2689-2697.1992","article-title":"Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts","volume":"66","author":"Brooks","year":"1992","journal-title":"J Virol."},{"issue":"3","key":"key\n\t\t\t\t20170522092625_KWU176C20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ijc.2910420305","article-title":"Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma","volume":"42","author":"F\u00e5hraeus","year":"1988","journal-title":"Int J Cancer."},{"issue":"6","key":"key\n\t\t\t\t20170522092625_KWU176C21","first-page":"1355","article-title":"Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia","volume":"146","author":"Pathmanathan","year":"1995","journal-title":"Am J Pathol."},{"issue":"20","key":"key\n\t\t\t\t20170522092625_KWU176C22","first-page":"471","article-title":"Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas","author":"de-The","year":"1978","journal-title":"IARC Sci Publ"},{"issue":"1","key":"key\n\t\t\t\t20170522092625_KWU176C23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910170102","article-title":"Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma","volume":"17","author":"Henle","year":"1976","journal-title":"Int J Cancer."},{"issue":"2","key":"key\n\t\t\t\t20170522092625_KWU176C24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/oxfordjournals.epirev.a036130","article-title":"Etiology of nasopharyngeal carcinoma: a review","volume":"15","author":"Hildesheim","year":"1993","journal-title":"Epidemiol Rev."},{"issue":"9","key":"key\n\t\t\t\t20170522092625_KWU176C25","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/1097-0142(19801101)46:9<2100::AID-CNCR2820460932>3.0.CO;2-G","article-title":"Nasopharyngeal carcinoma in Alaskan Eskimos Indians, and Aleuts: a review of cases and study of Epstein-Barr virus, HLA, and environmental risk factors","volume":"46","author":"Lanier","year":"1980","journal-title":"Cancer."},{"issue":"3","key":"key\n\t\t\t\t20170522092625_KWU176C26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ijc.2910280308","article-title":"Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA","volume":"28","author":"Lanier","year":"1981","journal-title":"Int J Cancer."},{"issue":"2","key":"key\n\t\t\t\t20170522092625_KWU176C27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ijc.2910260203","article-title":"Epstein-Barr virus-specific antibody titers in seven Alaskan natives before and after diagnosis of nasopharyngeal carcinoma","volume":"26","author":"Lanier","year":"1980","journal-title":"Int J Cancer."},{"issue":"3","key":"key\n\t\t\t\t20170522092625_KWU176C28","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/j.gastro.2009.05.001","article-title":"Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location","volume":"137","author":"Murphy","year":"2009","journal-title":"Gastroenterology."},{"issue":"3","key":"key\n\t\t\t\t20170522092625_KWU176C29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.bjc.6605146","article-title":"Epstein-Barr virus antibody level and gastric cancer risk in Korea: a nested case-control study","volume":"101","author":"Kim","year":"2009","journal-title":"Br J Cancer."},{"issue":"11","key":"key\n\t\t\t\t20170522092625_KWU176C30","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/sj.bjc.6604063","article-title":"Epstein-Barr virus serology and gastric cancer incidence and survival","volume":"97","author":"Koshiol","year":"2007","journal-title":"Br J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20170522092625_KWU176C31","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ijc.2910600513","article-title":"Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma","volume":"60","author":"Levine","year":"1995","journal-title":"Int J Cancer."},{"issue":"4","key":"key\n\t\t\t\t20170522092625_KWU176C32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/(SICI)1096-9071(200004)60:4<411::AID-JMV8>3.0.CO;2-8","article-title":"Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan","volume":"60","author":"Shinkura","year":"2000","journal-title":"J Med Virol."},{"issue":"2","key":"key\n\t\t\t\t20170522092625_KWU176C33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1349-7006.2007.00668.x","article-title":"Association of Epstein-Barr virus antibody levels with precancerous gastric lesions in a high-risk cohort","volume":"99","author":"Schetter","year":"2008","journal-title":"Cancer Sci."},{"issue":"2","key":"key\n\t\t\t\t20170522092625_KWU176C34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00043426-199122000-00019","article-title":"African Burkitt's lymphoma. History, biology, clinical features, and treatment","volume":"13","author":"Magrath","year":"1991","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"5673","key":"key\n\t\t\t\t20170522092625_KWU176C35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/274756a0","article-title":"Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study","volume":"274","author":"de-Th\u00e9","year":"1978","journal-title":"Nature."},{"issue":"4","key":"key\n\t\t\t\t20170522092625_KWU176C36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ijc.2910290406","article-title":"Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma","volume":"29","author":"Geser","year":"1982","journal-title":"Int J Cancer."},{"key":"key\n\t\t\t\t20170522092625_KWU176C37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-9378-5-13","article-title":"Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study","volume":"5","author":"Asito","year":"2010","journal-title":"Infect Agent Cancer."},{"issue":"6","key":"key\n\t\t\t\t20170522092625_KWU176C38","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/ijc.23254","article-title":"Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda","volume":"122","author":"Carpenter","year":"2008","journal-title":"Int J Cancer."},{"issue":"6","key":"key\n\t\t\t\t20170522092625_KWU176C39","doi-asserted-by":"crossref","first-page":"e2505","DOI":"10.1371\/journal.pone.0002505","article-title":"Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study","volume":"3","author":"Mutalima","year":"2008","journal-title":"PLoS One."},{"issue":"13","key":"key\n\t\t\t\t20170522092625_KWU176C40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM198309293091301","article-title":"Central-nervous-system lymphoma related to Epstein-Barr virus","volume":"309","author":"Hochberg","year":"1983","journal-title":"N Engl J Med."},{"issue":"8682","key":"key\n\t\t\t\t20170522092625_KWU176C41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","article-title":"Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma","volume":"335","author":"Harabuchi","year":"1990","journal-title":"Lancet."},{"issue":"12","key":"key\n\t\t\t\t20170522092625_KWU176C42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198803243181203","article-title":"T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections","volume":"318","author":"Jones","year":"1988","journal-title":"N Engl J Med"},{"issue":"4","key":"key\n\t\t\t\t20170522092625_KWU176C43","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/hupa.2002.124723","article-title":"AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment","volume":"33","author":"Carbone","year":"2002","journal-title":"Hum Pathol."},{"issue":"6","key":"key\n\t\t\t\t20170522092625_KWU176C44","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses","volume":"113","author":"Carbone","year":"2009","journal-title":"Blood."},{"issue":"2","key":"key\n\t\t\t\t20170522092625_KWU176C45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V82.2.619.619","article-title":"In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site","volume":"82","author":"Hamilton-Dutoit","year":"1993","journal-title":"Blood"},{"issue":"8773","key":"key\n\t\t\t\t20170522092625_KWU176C46","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0140-6736(91)91837-K","article-title":"Epstein-Barr virus in AIDS-related primary central nervous system lymphoma","volume":"338","author":"MacMahon","year":"1991","journal-title":"Lancet"},{"issue":"8","key":"key\n\t\t\t\t20170522092625_KWU176C47","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood.V81.8.2102.2102","article-title":"Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus","volume":"81","author":"Shibata","year":"1993","journal-title":"Blood."},{"issue":"2","key":"key\n\t\t\t\t20170522092625_KWU176C48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002030-200001280-00008","article-title":"B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS","volume":"14","author":"Grulich","year":"2000","journal-title":"Aids."},{"issue":"1","key":"key\n\t\t\t\t20170522092625_KWU176C49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaci.2008.04.034","article-title":"Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease","volume":"122","author":"Moir","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"14","key":"key\n\t\t\t\t20170522092625_KWU176C50","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1158\/0008-5472.CAN-11-0165","article-title":"Prediagnostic serum levels of cytokines and other immune markers and risk of non-Hodgkin lymphoma","volume":"71","author":"Purdue","year":"2011","journal-title":"Cancer Res."},{"issue":"7","key":"key\n\t\t\t\t20170522092625_KWU176C51","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1055-9965.EPI-11-0037","article-title":"B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma","volume":"20","author":"Breen","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"key\n\t\t\t\t20170522092625_KWU176C52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00051312","article-title":"Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies\u2013a prospective study","volume":"4","author":"Lehtinen","year":"1993","journal-title":"Cancer Causes Control."},{"issue":"3","key":"key\n\t\t\t\t20170522092625_KWU176C53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ijc.2910490313","article-title":"Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma","volume":"49","author":"Mueller","year":"1991","journal-title":"Int J Cancer."},{"issue":"4","key":"key\n\t\t\t\t20170522092625_KWU176C54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/10428190109099322","article-title":"Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma","volume":"42","author":"Hardell","year":"2001","journal-title":"Leuk Lymphoma."},{"issue":"18","key":"key\n\t\t\t\t20170522092625_KWU176C55","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2010-05-282715","article-title":"A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma","volume":"116","author":"Bertrand","year":"2010","journal-title":"Blood"},{"issue":"6","key":"key\n\t\t\t\t20170522092625_KWU176C56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.canep.2010.07.014","article-title":"Persistent infection by HCV and EBV in peripheral blood mononuclear cells and risk of non-Hodgkin's lymphoma","volume":"34","author":"Richiardi","year":"2010","journal-title":"Cancer Epidemiol."},{"issue":"9073","key":"key\n\t\t\t\t20170522092625_KWU176C57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(97)02088-6","article-title":"A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues","volume":"350","author":"Rothman","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"key\n\t\t\t\t20170522092625_KWU176C58","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3892\/or_00000389","article-title":"Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma","volume":"21","author":"Hardell","year":"2009","journal-title":"Oncol Rep."},{"issue":"10","key":"key\n\t\t\t\t20170522092625_KWU176C59","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1158\/1055-9965.EPI-13-0240","article-title":"Investigation of Epstein-Barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort","volume":"22","author":"De Roos","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"8","key":"key\n\t\t\t\t20170522092625_KWU176C60","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/ijc.22857","article-title":"Epstein-Barr virus infection and risk of lymphoma: immunoblot analysis of antibody responses against EBV-related proteins in a large series of lymphoma subjects and matched controls","volume":"121","author":"de Sanjos\u00e9","year":"2007","journal-title":"Int J Cancer."},{"issue":"2","key":"key\n\t\t\t\t20170522092625_KWU176C61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ijc.2910340203","article-title":"A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings","volume":"34","author":"Evans","year":"1984","journal-title":"Int J Cancer"},{"issue":"4","key":"key\n\t\t\t\t20170522092625_KWU176C62","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T","article-title":"Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data","volume":"70","author":"Glaser","year":"1997","journal-title":"Int J Cancer."},{"issue":"7","key":"key\n\t\t\t\t20170522092625_KWU176C63","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.1995.13.7.1758","article-title":"Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors","volume":"13","author":"Tirelli","year":"1995","journal-title":"J Clin Oncol."},{"key":"key\n\t\t\t\t20170522092625_KWU176C64","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/asheducation-2007.1.204","article-title":"Epstein-Barr virus and Hodgkin lymphoma","author":"Ambinder","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"18","key":"key\n\t\t\t\t20170522092625_KWU176C65","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood-2011-12-390823","article-title":"Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma","volume":"120","author":"Levin","year":"2012","journal-title":"Blood."},{"issue":"11","key":"key\n\t\t\t\t20170522092625_KWU176C66","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198903163201103","article-title":"Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis","volume":"320","author":"Mueller","year":"1989","journal-title":"N Engl J Med."},{"issue":"12","key":"key\n\t\t\t\t20170522092625_KWU176C67","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/ijc.26334","article-title":"Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis","volume":"130","author":"Mueller","year":"2012","journal-title":"Int J Cancer."},{"issue":"2","key":"key\n\t\t\t\t20170522092625_KWU176C68","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.84.2.570","article-title":"Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection","volume":"84","author":"Henle","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170522092625_KWU176C69","volume-title":"Epstein-Barr Virus","author":"Rickinson","year":"2007","edition":"5th ed."},{"key":"key\n\t\t\t\t20170522092625_KWU176C70","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/infdis\/jir645","article-title":"Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray","volume":"204(11)","author":"Zheng","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522092625_KWU176C71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1479-5876-7-73","article-title":"Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology","volume":"7","author":"Gu","year":"2009","journal-title":"J Transl Med"},{"issue":"2","key":"key\n\t\t\t\t20170522092625_KWU176C72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.2910290204","article-title":"Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China","volume":"29","author":"Zeng","year":"1982","journal-title":"Int J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20170522092625_KWU176C73","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ijc.2910360505","article-title":"Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA\/VCA antibody-positive persons in Wuzhou City, China","volume":"36","author":"Zeng","year":"1985","journal-title":"Int J Cancer."},{"issue":"4","key":"key\n\t\t\t\t20170522092625_KWU176C74","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000149391","article-title":"Follow-up studies on Epstein-Barr virus IgA\/VCA antibody-positive persons in Zangwu County, China","volume":"20","author":"Zeng","year":"1983","journal-title":"Intervirology."},{"issue":"1","key":"key\n\t\t\t\t20170522092625_KWU176C75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1097-0142(19920101)69:1<3::AID-CNCR2820690104>3.0.CO;2-7","article-title":"Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma","volume":"69","author":"Zong","year":"1992","journal-title":"Cancer."}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/180\/7\/687\/17342237\/kwu176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T08:35:33Z","timestamp":1689496533000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article-lookup\/doi\/10.1093\/aje\/kwu176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,28]]},"references-count":75,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,8,28]]},"published-print":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwu176","relation":{},"ISSN":["1476-6256","0002-9262"],"issn-type":[{"value":"1476-6256","type":"electronic"},{"value":"0002-9262","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8,28]]}}}